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ABSTRACT
The nucleobase modification 5-methylcytosine
(m
5C) is widespread both in DNA and different
cellular RNAs. The functions and enzymatic mecha-
nisms of DNA m
5C-methylation were extensively
studied during the last decades. However, the
location, the mechanism of formation and the
cellular function(s) of the same modified nucleobase
in RNA still remain to be elucidated. The recent
development of a bisulfite sequencing approach
for efficient m
5C localization in various RNA mole-
cules puts ribo-m
5C in a highly privileged position as
one of the few RNA modifications whose detection
is amenable to PCR-based amplification and
sequencing methods. Additional progress in the
field also includes the characterization of several
specific RNA methyltransferase enzymes in various
organisms, and the discovery of a new and unex-
pected link between DNA and RNA m
5C-
methylation. Numerous putative RNA:m
5C-MTases
have now been identified and are awaiting charac-
terization, including the identification of their RNA
substrates and their related cellular functions. In
order to bring these recent exciting developments
into perspective, this review provides an ordered
overview of the detection methods for RNA
methylation, of the biochemistry, enzymology and
molecular biology of the corresponding modifica-
tion enzymes, and discusses perspectives for the
emerging biological functions of these enzymes.
INTRODUCTION
Nucleotide modiﬁcations, a ubiquitous feature of life,
have ﬁrst been described in 1948, when the occurrence
of m
5C was detected in DNA (1). Today, about half a
dozen DNA modiﬁcations and more than 100 chemically
distinct RNA nucleotide modiﬁcations, including m
5C,
are known to be enzymatically synthesized. While
research into nucleotide modiﬁcations has been hampered
by limited performance of analytical methods, the ﬁeld has
recently encountered renewed interest. This is related to
the discovery of nucleotide modiﬁcations in regulatory
RNAs including siRNA, piRNAs, miRNAs and precur-
sors (2–7). Among the various modiﬁcations, a privileged
position is held by m
5C. This residue has been described in
several cellular RNAs and a complex enzymatic machin-
ery for its synthesis was found in representative organisms
from all kingdoms of life. In addition, recent data strongly
suggest its implication in the regulation of various biolog-
ical processes.
METHODS FOR m
5C DETECTION IN RNAs
Detection of nucleotide modiﬁcations is based on either
of three basic principles: (i) separation according to
physicochemical properties, (ii) diﬀerential enzymatic
turnover and (iii) diﬀerential chemical reactivity.
Separation according to physico-chemical properties
typically relies on chromatography, i.e. thin layer chroma-
tography (TLC), high-performance liquid chromatogra-
phy (HPLC), or mass spectrometry, and sometimes
on a combination of both (LC-MS). Most widespread
is the use of two-dimensional TLC. Because the migra-
tion characteristics of nearly 70 chemically distinct
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vent systems, identiﬁcation and quantiﬁcation of
32P-labeled nucleotides down to the femtomolar level is
straightforward (8). Although the use of in vitro substrates
containing a single type of labeled nucleotide by nearest
neighbor analysis permits the determination of the
nucleotide 30 to the modiﬁcation, the obligatory nuclease
degradation step before TLC analysis destroys most of
the modiﬁcation’s sequence context. For known modiﬁca-
tion sites, sequence speciﬁcity of the analysis can be
reintroduced by the use of DNAzymes (9) or
oligonucleotide-directed RNase H cleavage (10) prior to
labeling and TLC analysis. It has also been shown that
chemical conjugation of nucleotides to a ﬂuorescent dyes
and subsequent separation and detection by CE-LIF
allows quantiﬁcations of m
5C in DNA (11) in the
femtomolar range. A similar approach has also been
used for the detection of m
5C in RNA (12).
Similar to TLC and CE techniques, a typical LC-MS
analysis requires a complete nuclease digestion, which is
followed by dephosphorylation prior to separation on a
C18 reverse phase column. In addition to the retention
times, determination of the nucleosides’ molecular mass,
and/or their fragmentation pattern is used to conﬁrm the
chemical identity of a given modiﬁcation. Applications
of current LC/MS/MS techniques allow the detection of
modiﬁed nucleosides even in the sub-picomolar range (13).
Modiﬁcations can also be detected by LC-MS in
oligonucleotides obtained, e.g. by digestion with RNase
T1 (14), but sequence information is typically limited to
 10 nucleotides near the modiﬁcation site.
Since direct identiﬁcation through physico-chemical
properties prevents the use of PCR ampliﬁcation it also
prevents high throughput applications. While the ability
of certain nucleotide modiﬁcations to impede enzymatic
reactions such as ligations (15) or primer elongations
(16,17) can be used for sequence-speciﬁc detection, this
does not apply to m
5C, which behaves normally in terms
of Watson–Crick base pairing. However, a promising per-
spective is oﬀered by diﬀerential reactivity of m
5C towards
chemical reagents, which allows the application of
PCR-based ampliﬁcation steps, or aﬃnity-based enrich-
ment of m
5C-containing nucleic acids.
Distinct chemical reactivity of unmodiﬁed C and m
5C
Figure 1A illustrates the relevant reactive sites investigated
in 5-methyl and 20-deoxy-derivatives of cytidine. Of
foremost interest are the exocyclic N4-amino function
and the C5–C6 double-bond, because reactivities of both
sites are signiﬁcantly aﬀected by the introduction of a
methyl group on C5. Methylation generally increases
electron density in the aromatic ring by an inductive
eﬀect, which can be monitored by chemical shifts in
1H-NMR. Thus, C5-methylation of pyrimidines causes
an upﬁeld shift of  0.15p.p.m. in the H6 of both uridine
and cytidine (see the SDBSWeb: http://riodb01.ibase.aist
.go.jp/sdbs/ (National Institute of Advanced Industrial
Science and Technology, 14.7.2009)). This increase in
electron density favors reaction types such as oxidation
and electrophilic attacks, while disfavoring nucleophilic
attacks. There is clearly a strong interest to exploit these
features for the detection of methylated pyrimidines by a
combination of chemical and biochemical techniques.
Some of corresponding approaches will be outlined below.
Oxidation of the 5–6 double-bond in pyrimidines to the
corresponding glycol has been reported to result from
exposure to ionizing radiation or reagents such as
KMnO4, OsO4, or Fenton reagents (18–22). The concom-
itant loss of aromaticity renders the nucleic acid chain
susceptible to cleavage by aniline or piperidine in the
case of RNA or DNA, respectively (23–25). These reac-
tions are exploited for sequencing, structural probing, or
footprinting applications of end-labeled nucleic acids
(18,19). Although the permanganate reaction produces
insoluble MnO2, and further oxidation of the glycol to
the bis-aldehyde may occur under certain conditions, it
has been successfully employed in the discrimination of
deoxy-m
5C versus deoxycytidine (26). The osmium
tetroxide reactions do not involve the formation of insol-
uble products, but the reagent is highly toxic and
mutagenic. In the past years, a variety of osmate-based
bioconjugate reagents have been developed for the selec-
tive detection of m
5C in DNA. These reagents exploit the
additional electron density brought about by the methyl
group for highly selective formation of a stable complex
with deoxy-m
5C but not with deoxycytidine. However,
applications to RNA are still lacking (27).
Compared to cytidine, m
5C is more prone to spontane-
ous deamination of the N4 than cytidine in vivo (28). This
reaction is promoted by oxidizing conditions, and is
thought to involve the formation of an electron-deﬁcient
species, such as NO
+, which converts the N4-anilin
function into a leaving group which is then hydrolyzed
(29,30). Likewise, electrophilic alkylating agents
preferentially attack the nitrogen nucleophilic sites. Both
the N4- and the N3-aminofunctions are alkylated by
highly reactive agents such as ethylnitrosourea (ENU)
(31,32). The N3-methylation by dimethylsulfate (DMS)
has gained importance in Maxam and Gilbert style
sequencing techniques (24,25), as well as in structural
probing and footprinting of RNA and DNA (33,34). In
these biochemical applications, the N3-methylation
renders the aromatic ring electron poor and thus suscep-
tible to nucleophilic addition of hydrazine, which is
destroying aromaticity prior to chain scission (24,25).
Such nucleophilic additions are otherwise unusual in
pyrimidines, and require comparatively more stringent
conditions (24). Sodium bisulﬁte, also a nucleophilic
reagent, causes the deamination of cytosine residues in a
single-strand DNA through the initial formation a
5,6-dihydrocytosine-6-sulfonate intermediate at acidic
pH (Figure 1B). This implies a protonation step at the
5-position in conjunction with a Michael addition of the
nucleophile at the 6 position. Subsequent deamination
leads to 5,6-dihydrouracil-6-sulfonate from which the
5–6 double-bond is restored by beta-elimination during
the subsequent treatment under basic conditions.
Because this reaction occurs with selectivity for cytosine
over m
5C, its application to the detection of m
5C sites in
DNA has gained outstanding importance in an approach
called bisulﬁte sequencing (27).
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The principle of bisulﬁte sequencing is outlined in
Figure 2. A critical parameter is the fraction of intact
analyte nucleic acids surviving the sequential treatment
under acidic bisulﬁte and alkaline conditions (Figure 1B).
In these polymers, all cytidines are deaminated to uridines,
and will thus behave like thymidines in polymerase-based
sequencing or PCR-ampliﬁcation reactions while m
5C
residues remain unchanged and behave like cytidines.
Typically, the resulting fragments are PCR-ampliﬁed
before cloning and/or sequencing. Sequence alignments
arefacilitatedbysequencingofuntreatedsamples.Inalign-
ments of multiple bisulﬁte sequence reads, signiﬁcant
methylation is indicated by multiple occurrences of
cytidine signals at a given position. The sequencing
depth, i.e. the number of individual sequence reads in the
alignment, is thus an important quality parameter of the
analysis.
DNA bisulﬁte sequencing (35,36) has become an indis-
pensable tool for the mapping of m
5C in DNA, and its
continued development represents a key approach
towards characterizing the human epigenome (37,38).
An adaptation of the bisulﬁte treatment protocol to
the requirements of RNA showed that individual m
5C
residues in tRNA could be mapped by primer extension
(39). The same study also suggested that complex tRNA
modiﬁcation patterns could be analyzed by bisulﬁte
treatment of RNA samples, followed by reverse transcrip-
tion into cDNA, PCR ampliﬁcation, molecular cloning
and DNA sequencing of cloned PCR products.
However, no experimental details were provided for this
approach.
A stringent analysis of cytosine methylation patterns by
bisulﬁte sequencing requires very high cytidine to uridine
conversion rates of >95%. This is usually achieved only
after prolonged (>1h) incubation with sodium bisulﬁte,
which promotes degradation of DNA and, particularly,
RNA molecules and therefore reduces the eﬃcacy of the
ensuing PCR ampliﬁcation step. Sustaining high
deamination rates, and, at the same time, limiting the deg-
radation of RNA molecules thus represented the major
challenge for the establishment of an RNA bisulﬁte
sequencing protocol. This problem has recently been
solved by reducing the bisulﬁte reaction temperature
from 95 to 60 C, which permitted an extension of the
reaction time to 3h and more, without any major reduc-
tion in the eﬃcacy of the RT-PCR reaction (40). Under
these conditions, deamination rates of 97% and more
could be repeatedly achieved for single-stranded RNA
sequences.
High-throughput techniques of m
5C mapping and
quantiﬁcation in RNA
Initial tRNA bisulﬁte sequencing experiments indicated
a substantial variation in the cytosine methylation
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Figure 1. (A) Chemical reactivity of cytidine and m
5C. The methyl group of m
5C is shown in purple. Attack sites on the nucleobase are indicated by
arrows, where black indicates oxidizing agents, red indicates alkylating electrophiles and blue arrows indicate nucleophiles. Numbering of the
nucleobase atoms 1–6 is indicated inside the ring. Ribose carbon atom numbering is indicated by primed (0) numbers (B) Bisulﬁte mediated
conversion of cytosine to uracil. Nucleophiles, bases and nucleophilic attacks are indicated in blue, acids are indicated in red.
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methylation levels at speciﬁc positions therefore requires a
considerable sequencing depth of 100 (or more) sequence
reads. This can be achieved by next-generation sequencing
technologies, which permit the massively parallel
sequencing of hundreds of thousands single DNA mole-
cules. The sequencing depth provided by next-generation
sequencing also permits the analysis of complex methyla-
tion patterns. Indeed, 454 sequencing has recently been
used for the methylation analysis of various tRNA and
rRNAs and has facilitated the quantitative analysis of
RNA methylation patterns in these RNA molecules (40).
For 454 RNA bisulﬁte sequencing, PCR amplicons
are generated from deaminated RNA following reverse
transcription and then re-ampliﬁed with 454 primers
(Figure 2). The latter primers contain linker sequences
for the 454 sequencing technology and barcode sequences
for the bioinformatical identiﬁcation of individual
amplicons. Amplicons are then mixed, sequenced and
later subjected to bioinformatical analysis (40).
Importantly, the results obtained with these sequencing
approaches can also be used to robustly quantify the
methylation level of individual cytosine residues. It is con-
ceivable that RNA methylation can be used as a signal for
various cellular processes. In this context, the methyl
group would be a dynamic mark that can be added or
removed depending on intrinsic or extrinsic cues. Deep
sequencing of bisulﬁte amplicons therefore provides an
opportunity to use RNA methylation analysis as a
quantiﬁable assay for various biological questions.
Lastly, deep sequencing of cDNA libraries also permits
an additional quality control step that addresses the
PCR bias problem associated with most bisulﬁte-based
analytical tools. The biased PCR ampliﬁcation of
certain (c)DNA sequences represents a major problem
in the quantitative analysis of bisulﬁte sequencing experi-
ments, because it can result in a dramatic over- or
under-representation of particular PCR products (41). A
focused analysis of sequences with unique deamination
artifacts or the introduction of random sequence permu-
tations in an additional barcode patch in the reverse tran-
scription primer allows a 1:1 representation of RNA
molecules and sequence reads. These are important steps
towards the further optimization of the method that will
signiﬁcantly broaden its application potential.
THE PRESENCE OF m
5C IN VARIOUS
CELLULAR RNAs
m
5C is a prevalent modiﬁcation of many cellular RNAs.
Stable and highly abundant RNAs, like tRNAs and
rRNAs were extensively analyzed in the past by various
techniques. These studies allowed the precise mapping of
m
5C residues in tRNAs and also in ribosomal RNAs from
all three living domains.
tRNAs
While tRNAs from eubacterial organisms do not contain
m
5C, this modiﬁcation was detected in numerous archaeal
and eukaryotic tRNAs. For the best studied eukaryotic
tRNAs, m
5C residues seem to be clustered in the
junction between variable region and TC-stem, and posi-
tions 48 and 49 are most frequently modiﬁed. However,
other locations in the anticodon loop were also identiﬁed.
The same tendency exists also for archaeal tRNAs, where
the positions 48/49 are most frequently methylated,
but other methylation sites have also been reported.
In contrast to other organisms, higher eukaryota
frequently have an additional m
5C residue in the tRNA
acceptor stem, at position 72. The overall distribution of
m
5C-modiﬁed positions in yeast, archaeal and higher
eukaryotic tRNAs is shown in Figure 3 (42).
Prokaryotic and eukaryotic rRNAs
The presence of m
5C in ribosomal RNAs from diﬀerent
organisms was demonstrated by total digestion of highly
puriﬁed rRNAs followed by RP-HPLC and MS analysis
of the resulting nucleoside mixtures (43–46). Bacteria have
a variable number of m
5C residues; only three such mod-
iﬁcations are present in Escherichia coli rRNAs, while
rRNAs from Thermus thermophilus has ﬁve or six m
5C
residues (Figure 3B). Analysis of small and large subunit
rRNAs from bacteria and eukaryota similarly
demonstrated the presence of several m
5C residues in
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Figure 2. Principle of m
5C detection by RNA bisulﬁte sequencing and
combination with next-generation sequencing. The DNA primer
sequence for reverse transcription is adapted for C to U conversions
in the analyzed RNA.
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http://library.med.utah.edu/RNAmods/). More recently,
m
5C was also detected in archaeal rRNAs (47). In
addition, the locations of this modiﬁcation in rRNA are
rather well conserved from bacteria to humans.
Eukaryota have comparably fewer m
5C residues in
rRNA. Saccharomyces cerevisiae rRNA methylation
has not been exhaustively analyzed, but one m
5C residue
was mapped in 25S rRNA from S. carlsbergensis (48).
Similarly, human 28S rRNA contains only two m
5C
nucleotides (49) and no m
5C was detected in several
eukaryotic 18S rRNAs (50). Although very little is
known about eukaryotic mitochondrial rRNA
methylation, the presence of m
5C was reported for 18S
mt rRNA from the Syrian hamster Mesocricetus auratus
(the SSU rRNA Modiﬁcation Database, WEB http://134.
58.19.20/ssu/ssu.htm).
Analysis of archaeal rRNAs conﬁrmed the presence of
m
5C residues in SSU and LSU rRNAs, but demonstrated
that the number of modiﬁcations present in archaeal
rRNAs is highly variable. For example, no m
5C was
detected in Haloferax volcanii 16S rRNA, while its coun-
terpart from Sulfolobus solfataricus has at least one
residue in 16S rRNA and one or two m
5C in 23S rRNA
(47,51). For a comparative methylation analysis of
selected prokaryotic and eukaryotic rRNAs see Ref. (52).
m
5C in other cellular RNAs
Shortly after the discovery of nucleotide methylation in
the cap-structure of eukaryotic mRNAs, numerous inves-
tigations of the presence of methylated nucleotides
mRNAs and viral RNAs were reported. These were
typically based on pre-labeling with
3H-methionine,
which is converted to [
3H]S-adenosyl-L-methionine
(SAM) in living cells followed by incorporation of
3H–CH3 into RNA. Several studies reported the detection
of m
5C in mRNA from cultured BHK-21 hamster cells
(53), in S26 sindbis virus RNA from infected hamster
Figure 3. Occurrence of m
5C residues in tRNAs and rRNAs. The frequency of m
5C occurrence is color-coded in tRNA: yellow, <10%; orange,
between 10 and 30%; green, between 30 and 60%; blue >60%. Numbers in square brackets show the number of m
5C and number of unmodiﬁed or
other modiﬁed C at a given position [m
5C/C] The same color code is used for global distribution in all sequenced tRNAs, numbers are not shown for
clarity. Abbreviations: CY, cytoplasm; MI, mitochondria; ANI, animals; SIN, single cell eukaryota; PLA, plants; ARCHAE, Archaea. The lower
panel shows rRNA fragments from diﬀerent species with m
5C residues highlighted in blue.
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cells (56). However, no m
5C was found in mRNA from
HeLa cells (57,58), Novikoﬀ hepatoma cells (59), mouse
myeloma (60) and SV 40 viral RNA (61).
Certain ﬁndings suggest that classical tRNA modiﬁca-
tion enzymes may also methylate tRNA-like structures
in other RNA molecules. Thus, RNA derived from
tRNA-related short interspersed nuclear elements
(SINEs) was found to be methylated to m
5C in vitro (62),
although a recent analysis failed to detect m
5C methlyation
of this RNA in vivo (63). Moreover, the tRNA-like 30-end
of the Turnip Yellow Mosaic Virus (TYMV) RNA was
found to be methylated to m
5C upon injection into
Xenopus oocytes (64). It will be interesting to further
investigate the possibility that other cellular RNAs might
be methylated in order to fully understand the biological
function of this modiﬁcation (see below).
FAMILIES OF RNA: m
5C-MTases
The known enzymes transferring methyl groups from
SAM to nucleic acids belong to the SPOUT and
MTase superfamilies, the latter containing a Rossmann
fold for the accommodation of the cofactor (65).
RNA:m
5C-MTases represent a large protein family
which can be subdivided into several distinct groups, on
the basis of sequence similarity and RNA substrate
speciﬁcity. These subgroups are presented in Table 1.
The ﬁrst tentative approach towards a whole-genome
analysis of m
5C-MTases was initiated immediately after
the characterization of RsmB as a bacterial m
5C-MTase
(66). More than 30 homologous proteins were identiﬁed
by a BLAST search and a classiﬁcation into eight distinct
subgroups was proposed. However, only two E.coli genes
(RsmB and YebU) were listed, while the third bacterial
protein (YccW=RlmI) showed only little sequence
similarity to RsmB.
An exhaustive bioinformatical analysis of structure–
function relationships in the m
5C-MTase family was
later performed by Bujnicki et al. (65). The known
m
5C-MTases were subdivided into four major sub-families
(related to Nop2/Nol1, YebU/Trm4, a large group related
to RsmB or Ynl022c and a small group represented by
P.horikoshi PH1991 and human NSUN6). This classiﬁca-
tion is also used in Table 1.
Recently, a careful analysis of m
5C-MTase homologs in
higher eukaryota (67) suggested the existence of a new,
exclusively eukaryotic, subgroup of m
5C-MTase-related
proteins called RCMT9. These members are distantly
related to Trm4 and were detected only in Viridiplantae,
Alveolata, Euglenozoa and Mycetozoa taxons.
E. coli m
5C-MTases: activity, structure and substrates
All three known m
5C-MTases from E.coli were
extensively characterized, both biochemically and struc-
turally. Since m
5C in bacteria is only found in ribosomal,
Table 1. Known and some putative m
5C-MTRs and their RNA substrates
Enzyme
family
Enzyme
name
Other
names
Organism Life
domain
Accession Identiﬁcation
type
RNA
substrate
Modiﬁed
position(s)
X-ray
structure
Reference
RsmB family
RsmB/Nol1 RsmB Fmu/Fmv Escherichia coli B AP_004502 Biochemical 16S rRNA 967 1SQF,
1SQG
(68,70)
RsmB/Nol1 P120 NSUN1 Homo sapiens E P46087 NO Unknown NA (92)
RsmB/Nol1 Nop2 Saccharomyces cerevisiae E YNL061W NO Unknown NA (87)
RsmF/YebU family
YebU Haloferax volcanii A HVO_1594 Bioinformatics tRNA 39/40/48/49 (75)
YebU Pyrococcus abyssi A PAB1947 Biochemical tRNA Multiple
(mostly 49)
(79)
YebU aTrm4 Pyrococcus horikoshi A PH1374 Bioinformatics Unknown NA 1IXK (78)
YebU RsmF YebU Escherichia coli B P76273 Biochemical 16S rRNA 1407 2FRX (71,72)
YebU hTrm4 NSUN2/Misu Homo sapiens E NM_017755 Biochemical pre-tRNA
Leu 34 (86)
YebU FLJ22609 NSUN3 Homo sapiens E Q9H649 NO Unknown NA (65)
YebU MGC22920 NSUN4 Homo sapiens E Q96CB9 NO Unknown NA (65)
YebU Trm4 Ncl1 Saccharomyces cerevisiae E YBL024W Biochemical tRNA and
pre-tRNA
48/49 tRNA
34/40
pre-tRNA
(80,81)
Dnmt2 family
DNMT2 Dnmt2 Drosophila melanogaster E Q9U6H7 Biochemical tRNA 38 (102,107)
Dnmt2 trdmt1 Drosophila rerio E Q588C1 Biochemical tRNA 38? (122)
DNMT2 Dnmt2 Homo sapiens E O14717 Biochemical tRNA 38 1G55 (100,102)
DNMT2 Dnmt2 Mus musculus E O55055 Bioinformatics
DNMT3 pmt1 pmt1 Saccharomyces pombe E P40999 Bioinformatics
RlmI family
COG1092 RlmI YccW Escherichia coli B P75876 Biochemical 23S rRNA 1962 3C0K (73,74)
Ynl022 family
Ynl022c WBSCR20A NSUN5A Homo sapiens E Q96P11 NO Unknown NA 2B9E
Ynl022c WBSCR20B NSUN5B Homo sapiens E Q3KNT7 NO Unknown NA
Ynl022c WBSCR20C NSUN5C Homo sapiens E Q63ZY6 NO Unknown NA
Ynl022c WBSCR22 Homo sapiens E O43709 NO Unknown NA
Ynl022c NSUN7 Homo sapiens E Q8NE18 NO Unknown NA
Ynl022c Ynl022c Saccharomyces cerevisiae E YNL022C NO Unknown NA
NSUN6 family
NSUN6 NSUN6 Homo sapiens E Q8TEA1 NO Unknown NA
Abbreviations: A: archaea; B: bacteria; E eukaryota; NA not analyzed.
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their RNA target in a diﬀerential manner.
Fmu/fmv (RsmB). The Fmu/fmv protein from E.coli was
the ﬁrst identiﬁed and characterized RNA-speciﬁc
m
5C-MTase (68,69). A partially puriﬁed protein fraction
possessing 16S rRNA:m
5C967–MTase activity was
analyzed by N-terminal sequencing and was found to
match to the ﬁrst 23 amino acids of Fmu/fmv (later
renamed to RsmB). This is the ﬁrst and so far still the
only example for a biochemical identiﬁcation of an
RNA m
5C-MTase. With the exception of YccW(RlmI)
and Dnmt2-related proteins, all enzymes discussed below
have been identiﬁed by sequence similarity with the Fmu
protein and their activity was further conﬁrmed by various
in vivo and in vitro tests. RsmB from E.coli eﬃciently
catalyzes the methylation of naked 16S rRNA substrates,
but assembled 30S ribosomal subunits are not methylated
(68). In addition, a small 16-nt stem-loop minisubstrate
derived from E.coli 16S rRNA was methylated by
RsmB in vitro, albeit less eﬃciently than the full-size
rRNA transcript (69).
The crystal structures of RsmB alone and in complex
with SAM have been obtained at high resolution (1.65 and
2.1A ˚ , respectively) (70). RsmB folds into three almost
independent domains, a C-terminal domain that is respon-
sible for the m
5C-MTase activity, and two other domains
(the N-terminal domain and the central N1 domain)
that show signiﬁcant sequence similarity to known
RNA-binding proteins and that may mediate the interac-
tion with the 16S rRNA substrate. The crystal structure of
the RsmB–16S rRNA complex has not been published yet,
but docking of a 56-nt fragment derived from the 16S
rRNA substrate clearly demonstrated structure and
charge complementarity between the two molecules. In
this predicted conformation, the target cytosine comes
into close proximity with the catalytic Cys375 and the
activated methyl group of SAM. This overall structure
of the complex is consistent with the binding of a
completely folded rRNA substrate (70).
YebU (RsmF). Sequence similarity between RsmB and
an E.coli ORF encoded by the yebU gene suggested that
YebU also catalyzes m
5C formation in E.coli rRNA.
YebU was subsequently cloned and expressed, and its
activity was studied in vitro and in vivo (71). The results
demonstrated that the loss of active YebU protein led to
the concomitant loss of m
5C1407 in 16S rRNA, while
m
5C1962 in 23S rRNA remained unaﬀected. The
recombinant YebU protein (later renamed to RsmF)
retained its activity, but, in contrast to RsmB, methylated
only assembled 30S ribosomal subunits and not naked 16S
rRNA or complete 70S E.coli ribosomes.
Crystallized RsmF protein shows two distinct structural
domains, the m
5C-MTase domain, which resides in the
N-terminal part, and the C-terminal domain, which
shows signiﬁcant similarity to the PUA domain frequently
found in other RNA modiﬁcation enzymes, like RNA:
pseudouridine synthases and TGT-transglycosylases (72).
In silico docking of the 30S ribosomal subunit to the
RsmF structure suggests that it interacts not only with
16S rRNA but also with the ribosomal protein S12, pro-
viding a plausible explanation as to why naked 16S rRNA
is not a substrate for methylation.
YccW (RlmI). The last putative m
5C-MTase in E.coli
(YccW, now renamed to RlmI) has recently been
characterized. It is worth mentioning that RlmI only
distantly relates to two other E.coli m
5C-MTases (RsmB
and RsmF), and its sequence is closer to known
m
5U-MTases. Consequently, RlmI does not contain rec-
ognizable PC- and TC- sequence motifs present in other
m
5C-MTases and the catalytic Cys residue is located in the
SCS motif close to the C-terminus. On this basis, RlmI
was predicted to have pyrimidine-C5 MTase activity.
However, mass-spectrometric analysis of 23S rRNA
extracted from a YccW-deﬁcient E.coli strain clearly
linked RlmI activity to the unique m
5C1962 found in
E.coli 23S rRNA (73). Recombinant RlmI methylates
naked 23S rRNA, but not assembled 50S ribosomal
subunits, in spite of the rather high accessibility of the
target m
5C1962 at the subunit interface.
The crystal structure of RlmI has also become available
recently (74). The protein folds into three independent
domains, an N-terminal domain resembling the PUA
domain of other RNA modiﬁcation enzymes, a central
EEHEE domain that is common to other modiﬁcation
enzymes including m
5U-MTases and a C-terminal
catalytic m
5C-MTase domain. A model of the ternary
complex containing RlmI, SAM and an rRNA fragment
was analyzed by in silico modeling and subsequent mini-
mization of the structure. The results predicted an inter-
action between RlmI and single-stranded 23S rRNA,
rather than the folded and highly constrained
two-dimensional structure. This observation provides an
explanation for the inability of RlmI to methylate 50S
ribosomal subunits, even if the target cytosine residue is
highly accessible.
Archaeal m
5C-MTases
The number of putative m
5C MTases in Archaea is quite
variable. Only one related protein seems to be present in
mesophilic archaebacteria H.volcanii (75), while many
hyperthermophilic organisms display several homologous
proteins. The presence of m
5C in bulk tRNA fractions
extracted from P.furiosus and other hyperthermophilic
Archaea was ﬁrst demonstrated by HPCL/MS-ESI
analysis (76). Later on, activity tests performed with
cell-free P.furiosus extracts in vitro allowed the detection
of at least m
5C49- and, probably, m
5C40-forming activi-
ties acting on heterologous tRNA
Ile from H.volcanii and
yeast tRNA
Asp and tRNA
Phe substrates (77).
The analysis of numerous archaeal genomic sequences
demonstrated the presence of multiple putative
m
5C-MTases in many genomes. One of these proteins,
the ORF PH1374-encoded protein from P.horikoshi
showed signiﬁcant sequence similarity to the putative
human p120 m
5C-MTase (see below). The protein was
then recombinantly expressed and its structure was deter-
mined at 1.9A ˚ resolution (78). The RNA substrate of this
archaeal m
5C-MTase is not known, but its overall fold is
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RsmF, suggesting similar activity (72).
In the genome sequence of hyperthermophilic
P.abyssi, the ORF PAB1947 encodes a potential tRNA:
m
5C-MTase and forms a bicistronic operon with the
gene encoding archaease, a protein known to stabilize
several other archaeal proteins. ORF PAB1947 has been
expressed in E.coli and its activity was characterized
in vitro. The major methylation sites corresponded to the
expected positions 48 and 49 in a P. furiosus tRNA
Asp,
but surprisingly, other cytosines were also methylated,
especially at high incubation temperatures. Lower temper-
atures or the presence of archaease increased the
speciﬁcity of tRNA substrate recognition (79). These
data strongly suggest that archaeal m
5C-MTases may
have a rather broad speciﬁcity, compared to their yeast
or human counterparts.
Classes of eukaryotic m
5C-MTases
At least four distinct groups of RNA:m
5C-MTases, diﬀer-
ing in their sequence and RNA substrate speciﬁcity, were
found in diﬀerent eukaryotic organisms. Only three of
them were detected in S.cerevisiae, but all four groups
seem to be present in most eukaryotic genomes.
Yeast and human Trm4 (Ncl1). The S.cerevisiae Ncl1
protein was initially characterized as a nuclear protein of
unknown function (80). Further biochemical studies
demonstrated its role in the modiﬁcation of yeast
tRNAs and some tRNA precursors at positions 34, 40,
48 and 49. Positions 34 and 40 are modiﬁed only in the
intron-containing pre-tRNA and are speciﬁc for
tRNA
Leu(CAA) and tRNA
Phe(GAA), respectively (81).
On the basis of this ﬁnding, Ncl1 (encoded by ORF
YBL024) was renamed as Trm4 for tRNA-speciﬁc
MTase 4.
Structure–function relationships in yeast Trm4 were
further studied by various approaches like site-directed
mutagenesis and limited trypsin digestion. By these
methods, the catalytic role of Cys310 in motif IV was con-
ﬁrmed and the importance of the N-terminal domain for
cytosine methylation was identiﬁed. The C-terminal
domain is not required for tRNA binding and for catalysis
and seems to fold independently from the N-terminal part
of the protein. However, the presence of the C-terminal
domain of Trm4 considerably stimulates the MTase
activity of the N-terminal catalytic domain (82,83).
Sequence similarity with yeast Trm4 also allowed the
cloning and characterization of a human homologue
called hTrm4 or Misu/NSUN2. Misu/NSUN2 was
found to be involved in Myc-mediated proliferation of
cancer cells. It is expressed at low levels in normal epider-
mis but is up-regulated upon Myc activation (84). Misu/
NSUN2 is phosphorylated at Ser139 by the cell-cycle
protein kinase Aurora-B, and this phosphorylation
aﬀects its m
5C-MTase activity and its association with
nucleophosmin and nucleolin, two nucleolar interaction
partners (85). Despite its high similarity with the yeast
protein, the tRNA-MTase activity of hTrm4 seems to be
restricted to position 34 of the intron containing human
tRNA
Leu(CAA) (86). Human tRNA methyltransferases
mediating m
5C48/49 methylation still remain to be
identiﬁed.
Yeast and human Nop2/p120. The second member of the
family, the yeast S.cerevisiae nucleolar protein Nop2
(encoded by ORF YNL061) was shown to be involved
in biogenesis of 60S ribosomal subunit and in the matu-
ration of 26S rRNA (87,88). These functions of Nop2, and
not the putative RNA-MTase activity, are probably
important for the viability of yeast cells. Furthermore,
an RNA:m
5C-MTase activity or an RNA substrate for
Nop2 remain to be identiﬁed. Site-directed mutagenesis
of yeast Nop2 demonstrated that it has a Cys residue
(Cys424) essential for viability. All other tested amino
acid substitutions did not aﬀect Nop2 functions in vivo
(89). Further analysis showed that this Cys residue is
important for enzyme regeneration at the second step of
the reaction and its substitution by alanine or serine led to
the accumulation of a covalent intermediate attached to
the second catalytic cysteine (90) (see below). Genetic
analysis of Nop2 thermosensitive (ts) alleles allowed to
distinguish between the function as a 26S rRNA matura-
tion factor and a potential RNA:m
5C-MTase. These data
further conﬁrmed the role of Nop2 in 26S rRNA matura-
tion, even though the absence or reduced levels of Nop2
did not aﬀect 18S rRNA maturation or 40S subunit
biogenesis (91).
The strong sequence similarity of human proliferation
associated nucleolar protein p120 with yeast Nop2 and
the already characterized bacterial and eukaryotic
m
5C-MTases, together with its implication in rRNA
biogenesis, strongly suggested that p120 possesses a
similar activity (92,93). Experimental analysis of p120
delineated its N-terminal Arg-rich region as a high-aﬃnity
binding domain for rRNA. In addition, human p120 asso-
ciates with 60S–80S pre-ribosomal particles in HeLa
nuclear extracts (93). However, the signiﬁcance of this
physical association and the exact functions of human
p120 protein in rRNA maturation and processing
remain elusive.
The family of NSUN/NOP2/NOL1 related proteins in
humans is represented by at least nine diﬀerent members
(NSUN1 to NSUN7, genes NSUN5A, B and C probably
resulted from a recent gene duplication). Most genes of
this group are highly conserved in mammals. At the
protein level, the number of related protein variants is
very important since multiple mRNA splicing isoforms
were characterized and some variants may lack important
catalytic or RNA-binding domains. One of the NSUN
proteins (NSUN5A fragment 127–429) was crystallized
and its structure was determined at high resolution
(PDB accession 2B9E). In most cases, these NSUN
proteins retained the putative m
5C-MTase domain
bearing two catalytic cysteines. However, with the excep-
tion of hTrm4/NSUN2, neither the activity nor the
substrate speciﬁcity of these potential m
5C-MTases have
been investigated so far. NSUN5A, B and C are deleted in
Williams–Beuren syndrome, which is a complex develop-
mental disorder with multisystemic manifestations
including supravalvular aortic stenosis and a speciﬁc
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considerable sequence similarity to the third putative
m
5C-MTase in S.cerevisiae (encoded by ORF
YNL022C), which has not been characterized in detail
yet. Lastly, the human NSUN7 gene provides another
illustration for the implication of putative m
5C-MTases
in various disorders, because a point mutation in this
gene has been shown to cause reduced sperm motility
and infertility in male mice (95).
Higher eukaryotic Dnmt2 and homologs. A relatively new
addition to the eukaryotic RNA:m
5C-MTase family are
the Dnmt2-related proteins. The ﬁrst Dnmt2-like protein
(pmt1) was described in the ﬁssion yeast S.pombe (96) and
recognized by its substantial sequence homologies to
DNA:m
5C-MTases. It was also noted that the pmt1
protein sequence contained a serine insertion in the
catalytic proline–cysteine (PC) motif, which was inter-
preted to represent an inactivating mutation, consistent
with the absence of DNA methylation in ﬁssion yeast
(96). Several years later, human and mouse Dnmt2 were
discovered in screens for sequences with homologies to
known DNA:m
5C-MTases (97,98). The corresponding
protein sequences contained all the catalytic signature
motifs of DNA:m
5C-MTases, but no corresponding enzy-
matic activity could be described initially. Dnmt2 has been
widely conserved during evolution and the use of more
sensitive methods has allowed the identiﬁcation of a
residual DNA-MTase activity for Dnmt2. However, the
biological relevance of this activity has remained conten-
tious (99).
When the three-dimensional structure of human Dnmt2
was ﬁrst analyzed, the results demonstrated a high simi-
larity to the protein structure of the bacterial M.HhaI
DNA:m
5C-MTase (100), thus again suggesting that
Dnmt2 might have DNA-MTase activity. However, an
independent examination of the structural data also
identiﬁed a tyrosine residue in the target recognition
domain of Dnmt2 that was not present in other
DNA:m
5C-MTases (101). It was proposed that this
tyrosine residue might impede the binding of DNMT2
to DNA substrates and that the enzyme might thus
favor alternative substrates. This notion was conﬁrmed
when it was shown that Dnmt2 from various species
methylates C38 of tRNA
Asp (102). The tRNA-MTase
activity has now been conﬁrmed in several other
laboratories and appears to be substantially higher than
the residual DNA-MTase activity described initially. In
light of the ﬁndings discussed above, it appears reasonable
to assume that Dnmt2 is predominantly a tRNA-MTase
and that the weak and highly distributive DNA-MTase
activity is a consequence of a secondary enzyme activity
with potentially little biological relevance. A more recent
publication suggesting a role of Dnmt2-mediated DNA
methylation in the epigenetic regulation of transposable
elements in Drosophila (103) seems to contradict this
notion. However, the results from this study indicate a
robust and highly processive catalytic activity of Dnmt2
in the methylation of genomic retroelements. These
ﬁndings are surprising because they suggest that a sub-
stantial DNA-MTase activity of Dnmt2 has been
overlooked previously. It will therefore be important to
conﬁrm these results in independent assays and in other
model systems.
Subcellular localization of eukaryotic m
5C MTases
The subcellular localization of RNA modiﬁcation
enzymes can provide important indications about their
biological functions. Figure 4 gives an overview of the
current knowledge on the subcellular localization of
methylated RNAs and modiﬁcation enzymes. Most
m
5C-MTases are predicted to be nuclear or nucleolar
proteins which corresponds well to their functions in
tRNA and rRNA processing. Subcellular enzyme localiza-
tion has been studied experimentally, by using various
immunostaining and direct ﬂuorescence approaches, but
can also be inferred from the modiﬁcation pattern of RNA
in diﬀerent cellular compartments. This latter method is
particularly useful for mitochondrial localization, since
these small and very dynamic organelles are diﬃcult to
observe by microscopy and because mitochondrial
tRNAs and rRNAs are produced in the mitochondrial
matrix and may be modiﬁed only by mitochondria-
associated RNA modiﬁcation enzymes. For example,
yeast mitochondrial tRNAs do not contain m
5C even
though they contain many potential target cytosine
residues for Trm4 activity, thus indicating the absence of
Trm4 from this compartment.
Little is known about precise localization of various
m
5C-MTases in eukaryota. Yeast Ncl1 (Trm4) was
localized at nuclear periphery (80), while Nop2 is a
well-known nucleolar protein (88). Similarly, human
p120 is also nuclear and nucleolar (104). The subcellular
localization of Dnmt2 has been discussed controversially
with various studies providing indications for either a
nuclear or a cytoplasmic localization. A recent analysis
of the subcellular localization of Dnmt2 in Drosophila
suggested that the enzyme localizes both to the nucleus
and to the cytoplasm (105). This may be reﬂective of the
complex activities of Dnmt2.
THE CATALYTIC MECHANISM OF m
5C-MTases
The catalytic mechanism of m
5C-MTases bears strong
parallels to that of m
5U-MTases, including in particular
Trm2 which generates m
5U (also known as rT) at position
54 of most tRNAs. As opposed to most other RNA-
MTases, which methylate nitrogen atoms, the target
position of m
5-pyrimidine-MTases is a non-nucleophilic
carbon atom. Activation of this position proceeds
via Michael addition of a catalytic cysteine to the
6-position, which, after protonation, results in an
enamin in the case of m
5C-MTases (shown in
Figure 5A), or an enol in the case of m
5U-MTases
(not shown). The 5-carbon in these intermediates,
frequently referred to as ‘enolate’, is a nucleophile and
as such easily methylated by the electrophilic SAM.
Methyl-group transfer leads to another key intermediate,
a covalent adduct of enzyme and nucleic acid, from
which the enzyme is regenerated by beta-elimination
of cysteine and the hydrogen on C5, which is thought
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MTases extend to inhibition of the elimination step by
5-ﬂuoro-pyrimidine targets. Nucleic acids containing
5-ﬂurouracil or 5-ﬂuorocytidine frequently form covalent
adducts with cognate MTases (83).
The elucidation of the catalytic mechanism(s) of
m
5C-MTases continues to be critically important for
understanding the substrate speciﬁcity and biological
function of these enzymes. As outlined below, structural
biology with particular emphasis on the residues in active
sites has been combined with insights from bioinformatics
and biochemistry. The resulting picture discriminates
typical DNA- versus RNA-MTases, and identiﬁed
Dnmt2 as a hybrid RNA-MTase, which uses a catalytic
cysteine typical of DNA-MTase (see below).
Mechanism with two cysteines
Comparative studies of RNA- and DNA-speciﬁc
m
5C-MTases resulted in the conclusion that DNA and
RNA m
5C-methylation are being mediated by similar
yet distinct enzymatic mechanisms, which involve diﬀerent
amino acid residues (106). DNA and RNA-MTases
exhibit sequence permutations, resulting in a variable
linear order of the conserved motifs, which are
numbered I through X. Typical catalytic pockets of
RNA and DNA MTases are shown in Figure 6.
Typical RNA:m
5C-MTases contain two Cys-containing
characteristic motifs (motif IV and VI, referred to as
PC- and TC-sequences, respectively). However, only the
PC-sequence (motif IV) is found to be conserved in
DNA:m
5C-MTases, while motif VI contains a conserved
ENV-sequence. Site-directed mutagenesis of the E.coli
Fmu (RsmB) protein showed that only the replacement
of Cys375 (in motif VI, TC-sequence), but not Cys325
(in motif IV, PC-sequence) abolishes the RNA
m
5C-MTase activity in vitro and the capacity to form a
covalent adduct with 5-ﬂuoro-cytidine containing RNA.
These in vitro data came in apparent contradiction with
the results of site-directed mutagenesis of Nop2 in vivo
(89). Indeed, in this case, only a substitution of Cys424
(motif IV, PC-sequence) aﬀected the viability of yeast
cells. All other substitutions in Nop2 (including replace-
ment of Cys478 in motif VI) did not aﬀect Nop2 functions
in vivo. This apparent contradiction was resolved by
further studies (90) demonstrating that Nop2 and Trm4
(and probably other RNA:m
5C-MTases, like RsmB) use
both conserved cysteine residues for catalysis. The initial
activation of the cytosine ring is performed by the cysteine
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Nop2), while the release of the RNA substrate from the
covalent reaction intermediate requires the presence of the
second Cys in motif IV (PC-sequence, Cys424 in Nop2).
In the absence of the ‘regeneration’ Cys residue, the RNA
substrate is not released from the intermediate covalent
Nop2–RNA complex as indicated by the presence of
covalent adducts of higher molecular mass accumulating
in yeast cells and in E.coli. In the crystal structure of
E.coli RsmB, both Cys325 and Cys375 are located
in close proximity to each other and Cys325 aligns
well with Cys81, which is located in motif IV of the
HpaI DNA:m
5C-MTase. The spatial locations of
these conserved residues are thus fully compatible with
the proposed two-cysteine catalytic mechanism of
RNA:m
5C-MTases (70). More recently, the catalytic
mechanism involving both conserved Cys residues was
also conﬁrmed for yeast Trm4, which forms a stable
covalent intermediate with 5-ﬂuoro-cytidine containing
RNA (83).
A recent and intriguing addition to this ﬁeld is
the catalytic mechanism of the Dnmt2 m
5C-MTase.
Dnmt2 is an enzyme that has long been regarded as
pure DNA-MTase, based on sequence similarity with
other DNA-MTases, including a linear arrangement of
motifs I through X, which is characteristic for Dnmt
enzymes. The discovery of RNA-MTase activity in
Dnmt2 was thus a surprise (102). In subsequent studies
of human Dnmt2, mutational analysis identiﬁed essential
residues for analysis which include E119 (ENV-motif VI),
as well as R160 and R162 (motif VIII). The essential
catalytic cysteine, which conducts the initial nucleophilic
attack for tRNA methylation at position C38 was
identiﬁed as C79, which is situated in the PC-motif IV.
It was thus concluded, that C38 methylation of tRNA
by Dnmt2 utilizes a catalytic mechanism typical for
DNA-MTases (107). These ﬁndings uncover a previously
unexpected link between RNA and DNA methylation
which may be important for understanding the biological
function(s) of Dnmt2 (see below).
Covalent complex formation with the RNA substrate
Covalent complexes formed between RNA substrate and
mutant forms of RNA:m
5C-MTases have been observed
in several studies, but their detailed biochemical charac-
terization was not reported until recently. Site-directed
mutagenesis of yeast Trm4 conﬁrmed the importance of
motif VI Cys310 (TC-sequence) for catalysis and motif IV
Cys260 (PC-sequence) for substrate release. Trm4 C260A
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Nucleic Acids Research,2010, Vol.38, No. 5 1425or C260S mutants eﬃciently form covalent complexes
both in vitro and in vivo, when expressed in E.coli. SDS–
PAGE analysis showed that SAM is required for covalent
complex formation and that the RNA substrate is present
in a covalent complex that contains the CH3-group, an
indication that the release of the ﬁnal reaction product is
indeed impeded by the mutation in the PC-sequence (108).
THE BIOLOGICAL SIGNIFICANCE OF m
5C IN RNA
General stabilization of tRNA molecules and
Mg
2+ binding
A known general role of modiﬁed nucleotides in tRNA
is their structural and metabolic stabilization (109).
Structural stabilization of RNAs by m
5C was demon-
strated by various physico-chemical techniques, like
circular dichroism and NMR. One of the m
5C residues
present in the S.cerevisiae tRNA
Phe at position 40 was
reported to be important for appropriate Mg
2+ binding
and appears to induce conformational transitions of the
whole anticodon loop (110–112).
Modiﬁed residues in tRNAs are also known to inﬂuence
the stability of these molecules in vivo, and there are
at least two pathways that are known to degrade
hypomodiﬁed tRNA (113–115). An exosome-independent
pathway was found to degrade m
5C-deﬁcient tRNA, but
only in double mutants lacking both TRM4 and the
methyltransferase activity responsible for the formation
of 7-methylguanosine. The accelerated degradation of
hypomodiﬁed tRNA thus appears not to be speciﬁc to
the lack of single m
5C residues. Rather, it is hypothesized
that the combined lack of several modiﬁcations lowers the
conformational stability of the tRNA below a certain
threshold, which leads to its degradation by a mechanism
that is yet to be elucidated in detail (114,115).
Importance of m
5C for mRNA translation
Very little is known about speciﬁc role of m
5C residues
in tRNA and rRNA during mRNA decoding on
the ribosome. The presence of m
5C at position 34 in
eukaryotic tRNA
Leu seems to be important for its
function in translation, speciﬁcally for suppressor
function in vivo (116).
Deletion of the non-essential yeast TRM4 gene does not
aﬀect cell growth or steady-state levels of large and small
ribosome subunits, monoribosomes and polyribosomes.
However, disruption of TRM4 leads to increased sensitiv-
ity to the antibiotic paromomycin (80). Paromomycin is
known to aﬀect the precision of the ribosome decoding,
thus the presence of m
5C in yeast tRNA may be important
for maintenance of low error translation.
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5C in ribosomal RNA may also
participate in tRNA recognition and peptidyl transfer.
Despite their distant locations in the rRNA sequence, all
three m
5C residues present in bacterial 16S and 23S
rRNAs are localized in close proximity to each other
in the three-dimensional structure of the ribosome.
In addition, the paromomycin binding site has been
mapped precisely to this region (117). It is not clear if
yeast rRNA contains a m
5C residue at a similar
position, but the sensitivity of the YBL024 mutant to
paromomycin may indicate the relations between
ribosomal decoding and m
5C functions in rRNA (80).
Other biological functions of m
5C residues
Because the phenotypes of RNA:m
5C-MTase mutants
are comparably weak, it has generally been diﬃcult
to pinpoint the biological function of RNA cytosine
methylation. However, there is some direct evidence that
the methylation of RNA molecules can have a modulatory
eﬀect on the innate human immune system. Unmodiﬁed
RNA molecules have been shown to strongly stimulate the
immune system through activation of toll-like receptors
(118). This eﬀect was greatly reduced when either of
several methylated nucleotides, including m
5C, was incor-
porated into the stimulatory RNAs, suggesting that the
methylation prevents recognition of endogenous RNAs
by the innate immune system.
Another, currently more speculative role for RNA
methylation is the regulation of epigenetic inheritance
patterns. While it is clear that most phenotypic traits are
inherited through DNA, there is also evidence for
RNA-dependent inheritance of certain phenotypes (119).
The methylation of cytosine residues in DNA has long
been known to play an important role in the modulation
of genetic information (120). It will be fascinating to
explore the possibility whether RNA methylation plays a
similar role.
CONCLUSION AND PERSPECTIVES
Recent developments in the ﬁeld of RNA methylation
open a large perspective for further analysis of this impor-
tant biological process. Enzymatic activity, catalytic
mechanisms and RNA-recognition speciﬁcity of the
corresponding RNA:m
5C-MTases clearly require better
characterization. The biological role of m
5C residues in
RNA has been largely ignored and further studies using
genetically engineered models are needed to investigate
this point. High-throughput sequencing techniques will
be extremely helpful in the methylation proﬁling of low
abundance species [e.g. mRNA (53)], or even newly dis-
covered RNA species, including various regulatory RNAs.
While some of the latter are known to be methylated at
other positions such as the 20-OH, (6,121), veriﬁcation of
the presence or absence of m
5C in these species should
further deepen our understanding of the biological
meaning of m
5C in RNA.
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